drugset / Trial / NCT00226096

Intensive Blood Pressure Reduction in Acute Cerebral Haemorrhage

NCT00226096

RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of the study is to determine whether lowering high blood pressure levels after the start of a stroke caused by bleeding in the brain (intracerebral haemorrhage) will reduce the chances of a person dying or surviving with a long term disability. The study will be undertaken in two phases: a vanguard phase in 400 patients, to plan for a main phase in 2000 patients.

Timeline

Start
2005-11
Primary completion
2007-09
Completion
2007-09

Publications

Drugs

EvaluationDrugModalityDoseRoute
Background Clonidine Other / unclassified
Background ENALAPRILAT ANHYDROUS Small molecule
Background Esmolol Other / unclassified
Background Glyceroltrinitrate Unknown
Background Hydralazine Small molecule
Background Labetalol Small molecule
Background Metoprolol Other / unclassified
Background Nicardipine Small molecule
Background Phentolamine Small molecule
Background Urapidil Small molecule
Background nitroprusside Other / unclassified